Sort by
Search results
ZYMUTEST TAFI (Activatable)
Assay proposed for the measurement of TAFI in research applications.
ZYMUTEST TAFI (Total) Antigen
High TAFI Ag concentrations involve a hypofibrinolytic status, which can induce an elevated risk of thrombosis. Measurement of TAFI Ag on plasma in order to diagnose a risk of a hypofibrinolysis resulting from an excess of TAFI.
ZYMUTEST Tissue Factor
Assay proposed for the measurement of full length tissue factor in research application.
ZYMUTEST Tissue Factor Total
Assay proposed for the measurement of total tissue factor in research application.
ZYMUTEST tPA Antigen
Assay of tPA:Ag in clinical samples, as a disease marker. Assay of tPA:Ag in thrombolysis with recombinant tPA drugs. Assay of tPA:Ag as a cardiovascular disease marker.
ZYMUTEST vWF Antigen
Diagnosis of von Willebrand disease (vWD). Assay of vWF in clinical samples, as a disease marker or as an indicator for cardiovascular diseases. vWF deficiency associated with auto-antibodies to vWF (malignancy). High vWF concentrations in cardiovascular diseases.
ZYMUTEST vWF:CBA (Collagen Binding Assay)
Diagnosis of von Willebrand disease (vWD). Assay of vWF:CBA in clinical samples, as a disease marker or as an indicator for cardiovascular diseases.
ZYMUTEST β2-Glycoprotein-1 Antigen
Assay proposed for the measurement of β2GP1 antigen in research applications.
tPA Deficient Plasma
For all in-vitro -analyses that require human tPA deficient plasma.
tPA EIA
Supplied with full step-by-step instructions for performing sandwich ELISAs. For research use only.